NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

CAR-T治療的全球市場:到2030年的機會和策略,COVID-19的影響和恢復

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版商 The Business Research Company 商品編碼 977669
出版日期 內容資訊 英文 242 Pages
商品交期: 2-3個工作天內
價格
CAR-T治療的全球市場:到2030年的機會和策略,COVID-19的影響和恢復 CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
出版日期: 2020年12月21日內容資訊: 英文 242 Pages
簡介

本報告調查了全球CAR-T療法市場,包括市場規模和預測,趨勢和策略,增長和限制因素,COVID-19影響以及按應用,靶標抗原和地區進行的市場分析,提供競爭情況,主要公司的概況等。

目錄

第1章執行摘要

第2章目錄

第3章圖形列表

第4章表列表

第5章報表結構

第6章簡介

    • 區域細分
    • 按應用細分
    • 按靶抗原分割

第7章功能

  • 市場定義
  • 通過靶抗原進行市場細分
    • CD19治療
    • CD22治療
    • BCMA治療
    • 其他
  • 按應用細分市場
    • 急性淋巴細胞白血病
    • 瀰漫性大細胞B型淋巴瘤
    • 濾泡性淋巴瘤
    • 慢性淋巴細胞性白血病
    • 多發性骨髓瘤
    • 其他

第8章客戶信息

  • 醫生的興趣
  • 區域腫瘤學家對CAR-T治療的積極看法
  • 障礙被區域腫瘤學家視為招募中的挑戰
  • 改善CART細胞治療後的生活質量

第9章市場趨勢和策略

  • 改進的CAR-T細胞療法,副作用更少
  • 現有的同種異體CAR-T療法可改善治療
  • 用於治療高級神經膠質瘤的下一代CAR-T細胞
  • 機器學習和人工智能可優化未來的CAR-T治療
  • 與技術公司合作開發先進技術 擴大聯盟以推廣

第10章COVID影響分析

  • 對全球CAR-T治療的影響
  • 對全球臨床試驗的影響
  • 對全球主要腫瘤學家的影響

第11章全球市場規模和增長

  • 市場增長:銷售結果(2015-2019)
    • 市場增長因素
    • 市場約束因素
  • 市場增長:銷售預測(2019-2023、2025F,2030F)

第12章市場細分

  • 市場銷售表現/預測:按應用(2015-2019,2023F,2025F,2030F)
    • 瀰漫性大細胞B型淋巴瘤
    • 急性淋巴細胞白血病
    • 濾泡性淋巴瘤
    • 多發性骨髓瘤
    • 慢性淋巴細胞性白血病
    • 其他
  • 市場銷售表現/預測:按目標抗原劃分(2015-2019、2023F,2025F,2030F)
    • CD19
    • BCMA
    • 其他靶抗原
    • CD22

第13章市場分析:按地區/國家

  • 市場表現/預測:按地區劃分的銷售額(2015-2019、2023F,2025F,2030F)
  • 市場表現/預測:按國家/地區劃分的銷售額(2015-2019、2023F,2025F,2030F)

第14章亞太地區

第15章西歐

第16章東歐

第17章北美

第18章南美

第19章中東

第20章非洲

第21章競爭情況

  • 公司簡介
  • Giled科學
    • 公司簡介
    • 產品和服務
    • 經營策略
    • 財務概覽
  • 諾華公司

第22章管道分析

  • 癌細胞治療期間的臨床試驗:情況比較(2020年)
  • 按癌症類型分類:正在進行的臨床試驗數量
  • 按癌症類型分類:正在進行的臨床試驗數量
  • 通過測試地點:全球CAR-T細胞療法
  • 目標:臨床癌症試驗中的分子數量
  • CAR-T細胞療法流水線分析

第23章主要併購

  • ResTORbio與AdicetBio合併
  • Astellas Pharma收購XyphosBiosciences
  • Bristol Myers Squibb收購Celgene Corporation
  • Celgene 收購JunoTherapeutics
  • Gilead Sciences收購Cell Design Labs
  • Gilead Sciences收購Kite Pharma

第24章機會和策略

  • 2023年:提供最新機會的國家
  • 2023:提供最新機會的細分市場
  • 2023年:增長戰略
    • 基於市場趨勢的策略
    • 競爭對手策略

第25章結論/建議

  • 結論
  • 推薦

第26章附錄

目錄

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the CAR-T therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global CAR-T therapy market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics - The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report.
  • Customer Information - This chapter covers recent customers' trends/preferences in the global CAR-T therapy market
  • Trends And Strategies - This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the CAR-T therapy market.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players.
  • Pipeline Analysis - This chapter covers information about the drugs currently in pipeline
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global CAR-T therapy market is segmented into -

By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others

By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Companies Mentioned: Gilead Sciences; Novartis AG

Countries: USA, France, Germany, UK, China, India, Indonesia, Japan, South Korea, Australia, Russia, Brazil

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. CAR-T Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Application
    • 6.1.3. Segmentation By Target Antigen

7. CAR-T Therapy Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Target Antigen
    • 7.2.1. CD19 Therapy
    • 7.2.2. CD22 Therapy
    • 7.2.3. BCMA Therapy
    • 7.2.4. Others
  • 7.3. Market Segmentation By Application
    • 7.3.1. Acute Lymphoblastic Leukemia
    • 7.3.2. Diffuse Large B-Cell Lymphoma
    • 7.3.3. Follicular Lymphoma
    • 7.3.4. Chronic Lymphocytic Leukemia
    • 7.3.5. Multiple Myeloma
    • 7.3.6. Others

8. CAR-T Therapy Market Customer Information

  • 8.1. Interest Of Physicians
  • 8.2. Positive Perception Of Community Oncologists Towards CAR-T Therapy
  • 8.3. Challenges And Perceived Barriers In The Adoption Of CAR-T Therapy by Community Oncologists
  • 8.4. Improvement In Quality Of Life After CAR T-Cell Therapy

9. CAR-T Therapy Market Trends And Strategies

  • 9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects
  • 9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment
  • 9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma
  • 9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy
  • 9.5. Collaborating With Technology Companies For Advanced Technologies
  • 9.6. Growing Partnerships For Promoting CAR-T Therapy Market

10. CAR-T Therapy Market, COVID Impact Analysis

  • 10.1. Impact On Global CAR-T Therapy
  • 10.2. Impact On Global CAR-T Therapy Clinical Trials
  • 10.3. Impact On Leading Global Oncology Companies

11. Global CAR-T Therapy Market Size And Growth

  • 11.1. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 11.1.1. Drivers Of The Market 2015 - 2019
    • 11.1.2. Restraints On The Market 2015 - 2019
  • 11.2. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 11.2.1. Drivers Of The Market 2019 - 2023
    • 11.2.2. Restraints On The Market 2019 - 2023

12. Global CAR-T Therapy Market Segmentation

  • 12.1. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 12.1.1. Diffuse Large B-Cell Lymphoma
    • 12.1.2. Acute Lymphoblastic Leukemia
    • 12.1.3. Follicular Lymphoma
    • 12.1.4. Multiple Myeloma
    • 12.1.5. Chronic Lymphocytic Leukemia
    • 12.1.6. Others
  • 12.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 12.2.1. CD19
    • 12.2.2. BCMA
    • 12.2.3. Other Target Antigen
    • 12.2.4. CD22

13. CAR-T Therapy Market, Regional And Country Analysis

  • 13.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Asia-Pacific CAR-T Therapy Market

  • 14.1. Asia-Pacific CAR-T Therapy Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Market Information
    • 14.1.3. Impact of COVID-19
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investment
    • 14.1.12. Major Companies
  • 14.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Asia-Pacific CAR-T Therapy Market: Country Analysis
  • 14.6. China CAR-T Therapy Market
  • 14.7. China CAR-T Therapy Market Overview
    • 14.7.1. Country Information
    • 14.7.2. Market Information
    • 14.7.3. Impact of COVID-19
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes Levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investment
    • 14.7.12. Major Companies
  • 14.8. China CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.9. China CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.11. India CAR-T Therapy Market
  • 14.12. India CAR-T Therapy Market Overview
    • 14.12.1. Country Information
    • 14.12.2. Market Information
    • 14.12.3. Impact of COVID-19
    • 14.12.4. Background Information
    • 14.12.5. Government Initiatives
    • 14.12.6. Regulations
    • 14.12.7. Regulatory Bodies
    • 14.12.8. Major Associations
    • 14.12.9. Taxes Levied
    • 14.12.10. Corporate Tax Structure
    • 14.12.11. Investment
    • 14.12.12. Major Companies
  • 14.13. India CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.14. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.15. Japan CAR-T Therapy Market
  • 14.16. Japan CAR-T Therapy Market Overview
    • 14.16.1. Country Information
    • 14.16.2. Market Information
    • 14.16.3. COVID-19 Impact
    • 14.16.4. Background Information
    • 14.16.5. Government Initiatives
    • 14.16.6. Regulations
    • 14.16.7. Regulatory Bodies
    • 14.16.8. Major Associations
    • 14.16.9. Taxes Levied
    • 14.16.10. Corporate Tax Structure
    • 14.16.11. Investment
    • 14.16.12. Major Companies
  • 14.17. Japan CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.18. Japan CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.19. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.20. Australia CAR-T Therapy Market
  • 14.21. Australia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.22. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.23. Indonesia CAR-T Therapy Market
  • 14.24. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.25. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.26. South Korea CAR-T Therapy Market
  • 14.27. South Korea CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.28. South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Western Europe CAR-T Therapy Market

  • 15.1. Western Europe CAR-T Therapy Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Market Information
    • 15.1.3. Impact of COVID-19
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.5. Western Europe CAR-T Therapy Market: Country Analysis
  • 15.6. UK CAR-T Therapy Market
  • 15.7. UK CAR-T Therapy Market Overview
    • 15.7.1. Country Information
    • 15.7.2. Market Information
    • 15.7.3. Impact of COVID-19
    • 15.7.4. Background Information
    • 15.7.5. Government Initiatives
    • 15.7.6. Regulations
    • 15.7.7. Regulatory Bodies
    • 15.7.8. Associations
    • 15.7.9. Taxes Levied
    • 15.7.10. Corporate Tax Structure
    • 15.7.11. Major Companies
  • 15.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.9. UK CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.11. Germany CAR-T Therapy Market
  • 15.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.15. France CAR-T Therapy Market
  • 15.16. France CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.17. France CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. Eastern Europe CAR-T Therapy Market

  • 16.1. Eastern Europe CAR-T Therapy Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Market Information
    • 16.1.3. Impact of COVID-19
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.4. Eastern Europe CAR-T Therapy Market: Country Analysis
  • 16.5. Russia CAR-T Therapy Market
  • 16.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. North America CAR-T Therapy Market

  • 17.1. North America CAR-T Therapy Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Impact Of COVID-19
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. North America CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. North America CAR-T Therapy Market: Country Analysis
  • 17.6. USA CAR-T Therapy Market
  • 17.7. USA CAR-T Therapy Market Overview
    • 17.7.1. Country Information
    • 17.7.2. Impact Of COVID-19
    • 17.7.3. Market Information
    • 17.7.4. Background Information
    • 17.7.5. Government Initiatives
    • 17.7.6. Regulations
    • 17.7.7. Regulatory Bodies
    • 17.7.8. Major Associations
    • 17.7.9. Corporate Tax Structure
    • 17.7.10. Investments
    • 17.7.11. Major Companies
  • 17.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.9. USA CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. South America CAR-T Therapy Market

  • 18.1. South America CAR-T Therapy Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Major Companies
  • 18.2. South America CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.4. South America CAR-T Therapy Market: Country Analysis
  • 18.5. Brazil CAR-T Therapy Market
  • 18.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Middle East CAR-T Therapy Market

  • 19.1. Middle East CAR-T Therapy Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Impact of COVID-19
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Investments
    • 19.1.10. Taxes Levied
    • 19.1.11. Corporate Tax Structure
    • 19.1.12. Major Companies
  • 19.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.3. Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Africa CAR-T Therapy Market

  • 20.1. Africa CAR-T Therapy Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Impact Of COVID-19
    • 20.1.4. Background Information
    • 20.1.5. Government Initiatives
    • 20.1.6. Regulations
    • 20.1.7. Regulatory Bodies
    • 20.1.8. Major Associations
    • 20.1.9. Taxes Levied
    • 20.1.10. Corporate Tax Structure
    • 20.1.11. Major Companies
  • 20.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.3. Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. Global CAR-T Therapy Market Competitive Landscape

  • 21.1. Company Profiles
  • 21.2. Gilead Sciences
    • 21.2.1. Company Overview
    • 21.2.2. Products And Services
    • 21.2.3. Business Strategy
    • 21.2.4. Financial Overview
  • 21.3. Novartis AG
    • 21.3.1. Company Overview
    • 21.3.2. Products And Services
    • 21.3.3. Business Strategy
    • 21.3.4. Financial Overview

22. CAR-T Therapy Pipeline Analysis

  • 22.1. Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • 22.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
  • 22.3. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type
  • 22.4. Global CAR-T Cell Therapy By Trial Site
  • 22.5. Number of Molecules In Cancer Clinical Trails, By Target
  • 22.6. CAR-T Cell Therapy Pipeline Analysis

23. Key Mergers And Acquisitions In The CAR-T Therapy Market

  • 23.1. ResTORbio Merged With Adicet Bio
  • 23.2. Astellas Pharma Acquired Xyphos Biosciences
  • 23.3. Bristol Myers Squibb Acquired Celgene Corporation
  • 23.4. Celgene Acquired Juno Therapeutics
  • 23.5. Gilead Sciences Acquired Cell Design Labs
  • 23.6. Gilead Sciences Acquired Kite Pharma

24. CAR-T Therapy Market Opportunities And Strategies

  • 24.1. Global CAR-T Therapy Market In 2023 - Countries Offering Most New Opportunities
  • 24.2. Global CAR-T Therapy Market In 2023 - Segments Offering Most New Opportunities
  • 24.3. Global CAR-T Therapy Market In 2023 - Growth Strategies
    • 24.3.1. Market Trend Based Strategies
    • 24.3.2. Competitor Strategies

25. CAR-T Therapy Market, Conclusions And Recommendations

  • 25.1. Conclusions
  • 25.2. Recommendations
    • 25.2.1. Product
    • 25.2.2. Price
    • 25.2.3. Place
    • 25.2.4. Promotion
    • 25.2.5. People

26. Appendix

  • 26.1. Market Data Sources
  • 26.2. Research Methodology
  • 26.3. Currencies
  • 26.4. Research Inquiries
  • 26.5. The Business Research Company
  • 26.6. Copyright and Disclaimer